Researchers from the Fred Hutchinson Cancer Center in Seattle have tested a new HIV vaccine using mRNA, the technology behind many COVID-19 vaccines. Scientists say results from the early-stage clinical trial offer hope for significant progress in the global effort to develop a safe and effective HIV vaccine. For this episode of Weekend One on One, Angelica Waite has been speaking with Associate Professor Seth Cheetham, Deputy Director of BASE mRNA at the University of Queensland to learn more about the study, and what it means for HIV vaccine research
Nachrichten
SBS News In Depth Folgen
Hear the story behind the headlines. In each episode, we’ll help you make sense of the news stories that matter to you from Australia and the world, with reports and interviews from the SBS News team.
Folgen von SBS News In Depth
1634 Folgen
-
Folge vom 02.08.2025INTERVIEW: High hopes for new HIV vaccine
-
Folge vom 02.08.2025Tess watched as an atom bomb fell on Hiroshima. This is what she wants the world to knowAs the 80th anniversary of the Hiroshima atomic bomb approaches, one woman who narrowly escaped the blast has a warning about the terrible cost of war.
-
Folge vom 01.08.2025Australia spared tariff hike as Donald Trump raises rates for 92 nationsThe ructions from US tariff policy continue, with steeper rates announced by US President Donald Trump for 92 countries. It marks the end of decades of free trade by the US in favour of a protectionist approach - and the extent of the ripple effects remain to be seen.
-
Folge vom 01.08.2025What does a 10% US import tariff on Australian products mean for the economy and markets?SBS Finance Editor Ricardo Gonçalves speaks with Shane Oliver from AMP and Adam Dawes from Shaw and Partners to find out what a 10 per cent US import tariff on Australian products means for the economy and investors, plus is Canva making its way onto the sharemarket soon?